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Summary
Background.— Treatment of atrial ﬁbrillation (AF) by radiofrequency or cryoballoon ablation
requires good sedation and effective analgesia to be carried out safely and successfully.
Aim.— To compare analgesic and sedative drug usage during ablation procedures for paroxysmal
AF.
Methods.— The records of 60 patients hospitalized for ablation of paroxysmal AF were studied.
Patients were divided into two groups, according to the technique used: radiofrequency ablation
(group A) and cryoballoon ablation (group B). Anaesthetic and sedative medication usage was
compared between groups.
Results.— Patients’ mean age was 56.2± 1 years in the radiofrequency group and 57.0± 0.74
years in the cryoballoon group; mean duration of AF was 6.91± 2.36 and 6.77± 2.51 years,
respectively. Twenty patients from group A and 18 from group B had transesophageal echocar-
diography. With regard to sedative use, 3.01± 1.3mg/m2 of midazolam was used in group
A versus 3.5± 1.26mg/m2 in group B (p = 0.14). Propofol was seldom used. For analgesia,
Abbreviations: AF, Atrial ﬁbrillation; PV, Pulmonary vein; RF, Radiofrequency; TEE, Transesophageal echocardiography.
∗ Corresponding author. Fax: +33 476 76 56 23.
E-mail address: PDefaye@chu-grenoble.fr (P. Defaye).
875-2136/$ — see front matter © 2010 Elsevier Masson SAS. All rights reserved.
oi:10.1016/j.acvd.2010.06.004
Cryoballoon for pulmonary vein isolation 389
0.31± 0.26 g/m2 of paracetamol was used in group A versus 0.73± 1.86 g/m2 in group
B (p = 0.23). Mean morphine dose was higher in group A versus group B (3± 1.5 vs
2.09± 1.02mg/m2, respectively; p = 0.01).
Conclusion.— In this study, patients who underwent cryoballoon ablation required a lower
dose of morphine compared with those who underwent radiofrequency ablation. Catheter cry-
oballoon ablation appears better tolerated than radiofrequency ablation for the treatment of
paroxysmal AF.
© 2010 Elsevier Masson SAS. All rights reserved.
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Résumé
Justiﬁcation.— L’ablation par radiofréquence ou par cryo-énergie de la ﬁbrillation auriculaire
(FA) nécessite une bonne sédation et une analgésie efﬁcace.
Objectif.— Comparer les antalgiques et sédatifs durant les procédures d’ablation de FA parox-
ystique.
Méthodes.— Une étude rétrospective a été réalisée sur 60 patients hospitalisés pour ablation de
FA paroxystique, divisés en deux groupes ; groupe A : radiofréquence, groupe B : cryoablation.
Nous avons comparé l’utilisation des anesthésiques et sédatifs.
Résultats.— L’âge moyen était de 56,2± 1 ans pour le groupe A et 57± 2,51 pour le groupe B.
L’ancienneté de la FA était de 6,91± 2,36 ans pour le groupe A et de 6,77± 2,51 pour le groupe
B. Vingt patients du groupe A et 18 du groupe B ont eu une échocardiographie transœsophagi-
enne. Concernant les sédatifs, les doses utilisées ont été : 3,01± 1,3mg/m2 de midazolam pour
le groupe A et 3,5± 1,26mg/m2 pour le groupe B (P = 0,135). Le propofol était peu utilisé.
Concernant les analgésiques, les doses utilisées ont été : 0,31± 0,26 g/m2 de paracétamol pour
le groupe A, contre 0,73± 1,86 g/m2 dans le groupe B (P = 0,23) ; 3± 1,5mg/m2 de morphine
dans le groupe A contre 2,09± 1,02mg/m2 dans le groupe B avec une différence signiﬁcative
(p = 0,01).
Conclusion.— La cryoablation nécessite moins d’analgésiques que la radiofréquence d’après
notre étude. L’anesthésie légère offre une meilleure tolérance et assure un état de conscience
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Background
AF is the most frequent arrhythmia in clinical practice,
affecting 5% of people aged 65 years and 10% of those
aged over 80 years [1,2]. PV isolation by RF or cryobal-
loon ablation enables effective treatment of paroxysmal AF
[3].
Currently, RF is the gold standard ablation strategy for
paroxysmal AF [3]. However, this technique can be compli-
cated by stenosis of the PVs, thromboembolism, pericardial
effusion, complex left atrial ﬂutters and atrio-oesophageal
ﬁstula. Cryoballoon ablation has emerged as a valuable
alternative to RF ablation in the treatment of AF, with
complications that seem to occur less frequently. There has
been no description of atrio-oesophageal ﬁstula with cry-
oballoon ablation, while thromboembolic accidents and PV
stenosis are exceptional [4]. This technique creates smaller,
more circumscribed and reversible lesions, better stability
for energy delivery, and greater patient comfort with a lower
risk of pain [5].
In our experience, we can avoid and treat rapidly any
complications that might arise while carrying out these tech-
niques with the patient under conscious sedation, while
maintaining appropriate pain management. We therefore
initiated the present study to assess the requirements for
pain control with the two ablation techniques; our aim was
to compare the doses of analgesic and sedative drugs used
[
a
ls complications de fac¸on plus précoce.
s droits réservés.
uring the treatment of paroxysmal AF by RF ablation and
ryoballoon ablation.
ethods
tudy population
e studied the case ﬁles of 60 successive patients who had
blations after we considered that our proﬁciency in per-
orming both techniques was optimal. Thirty patients had
F ablation for paroxysmal AF while 30 had catheter cry-
balloon ablation for the same indication. Paroxysmal AF
s deﬁned as recurrent episodes of AF that self-terminate
n less than 7 days. Patients who required a hybrid tech-
ique with additional RF at the end of a catheter cryoballoon
blation procedure were excluded.
Our retrospective study included the following variables:
pidemiological data (age, sex, prior history); clinical data
weight, height, body surface area, duration of AF); ancillary
ata (whether TEE was used or not); and therapeutic data
ablation procedure [type of procedure, need for external
ardioversion, results, complications], medication dosage
2the medications used are expressed in mg/m ]).
Two groups were identiﬁed: group A (patients who had RF
blation) and group B (patients who had catheter cryobal-
oon ablation).
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naesthesia and analgesia
onscious sedation was administered by a nurse at the
irection of the physician. Initially, the patient received:
edatives (midazolam [Hypnovel®], 2—5mg if TEE; propofol
Diprivan®], 20mg if TEE difﬁcult); analgesics (paracetamol
Perfalgan®], 1 g at the start of the procedure; morphine,
mg). These doses were titrated by the physician to achieve
n adequate comfort level throughout the procedure. The
se of morphine is not systematic and depends on the
esponse to pain expressed by the patient through motion
r verbal communication. Electrocardiographic tracing and
ontinuous monitoring of heart rate, and respiratory and
xygen saturation were performed. Blood pressure was
onitored non-invasively every 5minutes. The doses of
naesthetic products were referenced to body surface area
sing the Boyd calculation formula (used most frequently in
linical research) [6]: body area (m2) = 0.0003207× (weight)
.7285-0.0188 × log (weight) × (height) 0.3; weight is in g (limit,
5—200 kg), height is in cm (limit, 99—250 cm) and the log
s decimal.
Anaesthetic and sedative medication dosages were com-
ared between the two groups.
adiofrequency procedure
or RF ablation, we used the same procedure as that
escribed by Haïssaguerre and coworkers [7]. After placing
iagnostic catheters into the coronary sinus, the interatrial
eptum was punctured as described before, and venogra-
hy of all four PVs was performed by introducing contrast
aterial through the transseptal sheath or through a 6-
rench multipurpose catheter into the proximal PVs. Next, a
ircumferential mapping catheter (Lasso, Biosense Webster
nc., Diamond Bar, CA, USA) was introduced into the prox-
mal PVs. An irrigated tip ablation catheter (ThermoCool,
iosense Webster Inc., Diamond Bar, CA, USA) delivering RF
nergy was introduced into the same hole. RF was applied
n a power-controlled mode with a power limit of 30W and
maximum temperature of 48 ◦C. Ablation was performed
t the atriovenous junction proximal to the circumferential
apping catheter at sites showing the earliest PV potentials,
erforming a segmental ablation of the PV ostia.
As in the cryoballoon group, acute isolation success
as conﬁrmed by the circumferential Lasso catheter in all
atients. Also, 20minutes after the last PV was ablated,
blation success was veriﬁed again in all PVs. Periprocedural
nd postprocedural anticoagulants were administered.
ryoballoon procedure
ll patients were treated with a double-lumen cryoballoon
Arctic Front, CryoCath Technologies, Montreal, Quebec,
anada), either 23mm or 28mm in size, as appropriate for
he diameter of the PVs. Both femoral veins were used for
enous access. A multipolar catheter (Woven, Bard Electro-
hysiology Inc., Lowell, MA, USA) was placed in the coronary
inus via the left femoral vein. Via the right femoral vein, we
sed a single standard transseptal approach with a Brocken-
rough needle (BRK Needle, St Jude Medical, St. Paul, MN,
SA) guided by ﬂuoroscopy and TEE, as required. We intro-
uced an 8-French SL1 sheath (FAST-CATH, St. Jude Medical,
T
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t. Paul, MN, USA) into the left atrium, then performed
ngiography of the PV with the catheter. We advanced and
ositioned a 10-pole Lasso catheter (Lasso 2515, Biosense-
ebster Inc., Diamond Bar, CA, USA) in the antrum of each
ein to demonstrate the presence of electrical activity in the
eins. For the left PV, pacing in the distal coronary sinus was
ecessary to conﬁrm PV potentials. After this conﬁrmation,
e proceeded with the ablation without continuous Lasso
onitoring.
We removed the SL1 sheath and advanced a 12-French
teerable sheath (FlexCath, CryoCath Technologies, Mon-
real, Quebec, Canada) ‘‘over the wire’’ (0.032 inch, 180 cm
uper Stiff G.W., St Jude Medical, St. Paul, MN, USA) into the
eft atrium. The Arctic Front balloon catheter was intro-
uced inside the 12-French sheath and positioned over a
ire guide (Amplatz Extra Stiff Wire Guide, 0.032 inch, Cook
roup Incorporated, Bloomington, IN, USA). We selected
ither a 23mm or a 28mm Arctic Front cryoballoon in accor-
ance with PV diameters. The cryoballoon catheter was
ositioned in such a way as to occlude the ostium of each
V after inﬂation. Cryoablation was applied for 4minutes
t least twice for each vein and directed toward the major
ide branches with the use of the guide wire. We tried for at
east one cryoablation application with full occlusion (grade
) on each targeted vein. When the extent of occlusion was
ot optimal, we changed the position of the balloon or ﬂex-
on of the sheath to achieve better occlusion. The ablation
rocedure was always started in the left superior PV, then
roceeded to the left inferior PV, followed by the right infe-
ior PV, and ﬁnally, the right superior PV.
Whenever we targeted the right PVs, we positioned the
asso catheter in the superior caval vein for continuous
hrenic nerve stimulation during cryoablation application.
s the proximity of the phrenic nerve to the right-sided veins
annot be ascertained, this vigilance is essential in order
o prevent phrenic nerve palsy. If phrenic nerve capture
eased, the ablation was stopped instantly due to the oper-
tor’s continuous monitoring. After targeting all the PVs, we
eintroduced the Lasso catheter into the veins to verify that
omplete electrical disconnection was achieved during sinus
hythm and pacing. The procedure was performed under full
nticoagulation with heparin.
tatistical analysis
tatistical analysis was done using the SPSS software pro-
ram, version 10.0 (SPSS Inc., Chicago, IL, USA). The
ariables studied were expressed as means± standard devi-
tions.
Continuous data were compared between the two groups
y the unpaired t-test and ordinal data were compared in
oth groups using the chi-square test. A value of p < 0.05 was
onsidered to be statistically signiﬁcant.
esultshe demographic and anthropometric characteristics of
oth groups are summarized in Table 1.
For the population in group A, the mean duration of AF
as 6.91± 2.36 years (range, 0.16—30 years) and the under-
ying diseases were four cases of hypothyroidism and one
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Table 1 Comparison of epidemiological and morphological data in the two groups.
Variable Group A
(Radiofrequency group)
(n = 30)
Group B
(Cryoablation group)
(n = 30)
P value
Age (years) 56.2± 1 (range 78—32) 57± 2.51 (range
77—43)
0.94
Sex ratio (men/women) 2.5:1 1 4:1 0.55
Weight (kg) 74.16± 2.3 (104—47) 76.6± 2.1 (110—53) 0.84
Height (m) 1.71± 0.3 (1.8—1.5) 1.72± 0.5 (1.9—1.5) 0.99
Body surface area (m2) 1.88± 1.7 (2.3—1.48) 1.92± 1.2 (2.42—1.56) 0.98
Data (other than sex ratio) are mean± standard deviation (range).
Table 2 Proportion and comparison of patients who had transesophageal echocardiography in the two groups.
Group A(Radiofrequency group)(n = 30) Group B(Cryoablation group)(n = 30) P value
TEE+ 20 (66.7) 18 (60.0) 0.74
TEE− 10 (33.3) 12 (40.0) 0.66
Data are number (%).
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iTEE+: patients required transesophageal echocardiography; TEE−
case, respectively, of hyperthyroidism, tachycardia-induced
cardiomyopathy, valvular heart disease and sick sinus syn-
drome. For the population in group B, the mean duration of
AF was 6.77± 2.51 years (range, 1—22 years) and the under-
lying associated diseases were four cases of hypothyroidism
and one of tachycardia-induced cardiomyopathy.
TEE was carried out inside the catheter laboratory,
in case of difﬁcult transseptal puncture. Twenty patients
(66.7%) in group A and 18 patients (60.0%) in group B
required TEE (p = 0.74; Table 2). Cardioversion was neces-
sary for two patients in group B and one patient in group A
at the end of the procedure.
In order to obtain good sedation and analgesia in our
patients, we used sedatives such as midazolam and propo-
fol and analgesics such as morphine and paracetamol. We
compared the mean doses of these products in both groups
(Table 3). Propofol was used in two patients in group A and
four patients in group B.
In the immediate follow-up after the ablation, we noted
four complications in group B (1.3%; one case of pericar-
dial effusion, one case of self-limiting mediastinal effusion
c
K
a
T
t
Table 3 Anaesthetic and analgesic drugs used during the abla
Drugs Population Number of patien
Midazolam (mg/m2) Group A 30
Group B 30
Morphine (mg/m2) Group A 30
Group B 30
Paracetamol (g/m2) Group A 30
Group B 30
Group A is the radiofrequency group; group B is the cryoablation groupients did not require transesophageal echocardiography.
nd two cases of transient phrenic paralysis) and two
omplications in group A (0.6%; transient phrenic paraly-
is and pericardial effusion). The pericardial effusion was
rained uneventfully.
iscussion
his study concerned two techniques (RF and
atheter cryoablation) in the treatment of paroxysmal
F.
Both groups of patients were similar in terms of demo-
raphic and anthropometric characteristics. Our study
opulation had similar demographic and anthropometric
haracteristics to those of populations from other stud-
es addressing similar pathology. In two recent studies on
atheter cryoablation and RF ablation for paroxysmal AF,
lein et al. [8] and Reant et al. [9] found, respectively: mean
ge, 59 and 56 years; mean duration of AF, 6.5 and 9.2 years.
hese demographic and anthropometric data are similar to
hose found in our study.
tion procedures in the two groups.
ts Mean Standard deviation P value
3.01 1.35 0.135
2.50 1.26
3.0 1.53 0.010
2.09 1.02
0.31 0.26 0.230
0.73 1.86
.
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Isolation of the PVs during AF ablation was carried out
nder light sedation and with intravenous analgesia. This
nabled us to maintain the patient in a state of sufﬁcient
wareness to be able to warn us if there was any sign sug-
esting a complication. The complications we encountered
ere no different from the usual complications associated
ith ablation procedures for AF (pericardial effusion, medi-
stinal effusion and transient phrenic paralysis) [10]. The
ew complications recorded were spontaneously reversible.
f note, we did not recognize any embolic event in our 60
atients.
A comparison of the anaesthetic and analgesic medi-
ation used enabled us to estimate the pain associated
ith each of the two techniques. Additional procedures
hat necessitated an increase in anaesthetic or analgesic
oses were carried out in similar proportions in both groups.
wenty patients (66.6%) in group A and 18 patients (60.0%)
n group B had a TEE (p = 0.74). Cardioversion was required
or one patient in group A and two patients in group B.
edative and hypnotic drugs
edative and hypnotic drugs were used systematically at
he beginning of the procedure, regardless of the technique
sed. Midazolam is a benzodiazepine with a short life (mean
alf-life, 3 hours [11]), which is used in most semi-invasive
nd invasive procedures in adults and children [12—14]; it
rovides lower anxiety and good sedation. For group A, a
ean dose of 3.01± 1.3mg/m2 of midazolam was used com-
ared with 3.5± 1.26mg/m2 for group B (non-signiﬁcant
ifference; p = 0.135).
This lack of difference between the two groups is related
o the fact that midazolam was administered systematically,
rrespective of the procedure and the patient’s anxiety.
ropofol was seldom used in our patients (two patients in
roup A and four patients in group B); all these patients had
EE. This low usage of propofol is due to the fact that it
s a product that has haemodynamic and respiratory side
ffects; it is very helpful if TEE is needed and its manage-
ent often requires the presence of anaesthesia support
12].
ntravenous analgesic drugs
ntravenous doses of paracetamol and morphine referenced
o weight were administered systematically to patients at
he beginning of the procedure. The doses of morphine
ere then increased depending on the pain felt by the
atient. These symptoms were dominated by headaches and
oothache in cryoballoon ablation, while back and shoulder
ain occurred more frequently in RF applications.
In group A, a mean dose of 0.31± 0.26 g/m2 of parac-
tamol was used compared with 0.73± 1.86 g/m2 in group
(non-signiﬁcant difference; p = 0.23); a mean dose of
± 1.5mg/m2 of morphine was used in group A compared
ith 2.09± 1.02mg/m2 in group B (statistically signiﬁcant
ifference; p = 0.01). It is apparent that a larger dose of mor-
hine was used in patients who underwent RF compared with
n those who underwent cryoballoon ablation. The increase
n the dose of morphine in our series was related to the
resence of often unbearable pain felt by the patient dur-
ng ablation, generally during RF. These data conﬁrm thatP. Defaye et al.
F cryoballoon ablation, which uses a more gentle form of
nergy than RF, is better tolerated [15].
There were no complications relating to anaesthesia or
nalgesia in either group; these drugs are usually well tol-
rated and enable physicians to carry out procedures with
reater safety levels [16].
tudy limitations
lthough this was, to our knowledge, the ﬁrst study concern-
ng this matter, the number of patients enrolled was limited
nd it was not a randomized study. Even though there was
clearly statistically signiﬁcant ﬁnding, we cannot entirely
xclude it being due to chance. In addition, as there is no
ccurate means of measuring an individual patient’s reac-
ion to pain, this remains an entirely subjective assessment.
t would be useful to compare the perception of pain in both
roups on a visual analogue scale [17].
onclusion
he use of light anaesthetic and analgesic products
ecreases pain and anxiety in patients, while maintain-
ng a state of consciousness, enabling them to alert the
hysician to pain during ablation procedures for paroxysmal
F. According to our study, catheter cryoballoon ablation
equired less analgesic than RF ablation. Catheter cryobal-
oon ablation would therefore seem to be better tolerated
han RF ablation for the treatment of paroxysmal AF. Apart
rom this better tolerance, it is a technique that offers
reater comfort for the practitioner, the patient and the
ursing staff, as well as less risk of drug overdosing. The use
f lower doses of anaesthetic products in catheter cryobal-
oon ablation makes this technique much simpler to use and
nvolves less risk for the patient, theoretically. According to
he available literature, our results are similar to those from
ther studies of RF in the treatment of paroxysmal AF.
A prospective study on the use of sedatives and anal-
esics, with collection of side effects and symptoms of
atients during the ablation procedures for AF, would pro-
ide conﬁrmation of current study ﬁndings.
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